Information about 2023 ASDS Research Grant coming April 2023!

Jumpstart Research Seed Grant Program 

The intention of this program is to encourage and support only the highest quality research and training in areas related to dermatologic surgery. The Jumpstart Research Seed Grant Program serves as a catalyst to develop research initiatives for ASDS members. The purpose is to give research investigators a chance to define objectives, test hypotheses and provide a better idea of feasibility and directionality of research before applying for additional funds from ASDS or other external sources.

Under education and innovation in dermatologic surgery, the Jumpstart progam will award up to $10,000.

Contact education with any questions.


Submit research proposals relevant to:

  • Core surgical procedures and techniques
  • Cosmetic medicine and surgery
  • Cutaneous oncology
  • New technologies
  • Board-directed research topics

Cutting Edge Research Grant Program (CERG)

Supporting its mission to foster, support, develop and encourage investigative knowledge in dermatologic surgery, ASDS provides members with the tools and assistance they need to achieve the highest standards in clinical practice and patient care.

Under education and innovation in dermatologic surgery, the CERG progam will award up to $40,000 this year to stimulate research relevant to dermatologic surgery and/or cutaneous oncology. 



2022 Jumpstart Research Seed Grant Recipients


Adam Miller, MD

Topic: Temporal Characterization of the Cutaneous Microbiome in the Perioperative Period
Institution: UC San Diego Health System

Neha Jariwala, MD

Topic: Studies in the Surgical Management of Arcal Melanoma
Institution: University of Pennsylvania 


2022 Cutting Edge Research Grant Recipient

Emily Ruiz, MD

Topic: Cutaneous Sarcoma Outcomes Analysis of a tumor characteristics and treatment modality
Institution: Brigham & Women's Hospital

2020-21 Winners

2020 CERG Winners
  • Ashley Elsensohn, MD 
    University of California San Diego
    Topic: Use of Preferentially Expressed Antigen in Melanoma (PRAME) immunohistochemistry for margin control of melanoma in-situ during Mohs micrographic surgery
  • Steven Barilla, MD 
    Northwell Health, Department of Dermatology
    Topic: Patient Preferences Regarding Virtual Visits in Cutaneous Surgery in the era of COVID-19: A Patient-Centered Investigation from an Academic Dermatologic Surgery Practice